PMDA drug package insert
ビーエスエスプラス500眼灌流液0.0184%
PMDA Prescription drug · 日本アルコン株式会社 · package insert Jan 25, 2022
Key facts
| Brand names | ビーエスエスプラス500眼灌流液0.0184% |
|---|---|
| Nonproprietary names | オキシグルタチオン |
| Companies | 製造販売元（輸入元）／日本アルコン株式会社 |
| Product type | Prescription drug |
| Therapeutic category | オキシグルタチオン眼灌流・洗浄液 |
| Therapeutic category codes | 871319 |
| YJ codes | 1319731Q2045 |
| Approval numbers | 22000AMX00581000 |
| Package insert edition | 第1版 |
| Package insert date | Jan 25, 2022 |
| PMDA document key | 400487_1319731Q2045_1 |
| PMDA company code | 400487 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: